| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |